{{Rsnum
|rsid=1867504
|Gene=TFP
|Chromosome=3
|position=133691817
|Orientation=plus
|GMAF=0.4187
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 18.6 | 56.6 | 24.8
| HCB | 28.5 | 51.8 | 19.7
| JPT | 26.5 | 44.2 | 29.2
| YRI | 6.8 | 32.0 | 61.2
| ASW | 12.3 | 38.6 | 49.1
| CHB | 28.5 | 51.8 | 19.7
| CHD | 25.7 | 50.5 | 23.9
| GIH | 27.7 | 51.5 | 20.8
| LWK | 4.5 | 30.9 | 64.5
| MEX | 24.1 | 44.8 | 31.0
| MKK | 6.4 | 42.9 | 50.6
| TSI | 24.5 | 44.1 | 31.4
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=19084217
|Trait=Serum markers of iron status
|Title=Variants in TF and HFE explain approximately 40% of genetic variation in serum-transferrin levels
|RiskAllele=
|Pval=0.000002
|OR=NR
|ORtxt=NR
|OA=1
}}

{{PharmGKB
|RSID=rs1867504
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:19084217; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Variants in TF and HFE explain approximately 40% of genetic variation in serum-transferrin levels. (Initial Sample Size: 459 twin pairs; Replication Sample Size: NR); (Region: 3q22.1; Reported Gene(s): TF; Risk Allele: rs1867504-?); (p-value= 0.000002).This variant is associated with Serum markers of iron status.
|Drugs=
|Drug Classes=
|Diseases=
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA164740106
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs1867504
|overall_frequency_n=77
|overall_frequency_d=128
|overall_frequency=0.601562
|n_genomes=45
|n_genomes_annotated=0
|n_haplomes=67
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | Illumina Human 1M}}